PDS BIOTECHNOLOGY CORP (PDSB) Institutional Ownership Changes & 13F Activity
PDS BIOTECHNOLOGY CORP (PDSB). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Militia Capital Management Llc, Susquehanna International Group, Llp, Renaissance Technologies LLC, Morgan Stanley, and Acadian Asset Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Susquehanna International Group, Llp | Buy | +754,076 | +2075.7% | 790,404 | $593.36K | Q3 2026 | Nov 16, 2026 |
| Xtx Topco Ltd | Buy | +83,077 | +251.0% | 116,175 | $87.21K | Q3 2026 | Nov 16, 2026 |
| Two Sigma Securities, Llc | Sell | -28,221 | -68.2% | 13,170 | $9.89K | Q3 2026 | Nov 16, 2026 |
| Iron Gate Global Advisors Llc | Sell | -12,033 | -17.1% | 58,373 | $43.82K | Q3 2026 | Nov 16, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -2,363 | -59.9% | 1,579 | $1.19K | Q3 2026 | Nov 16, 2026 |
| Federation Des Caisses Desjardins Du Quebec | Buy | +2,000 | +10.1% | 21,800 | $16.37K | Q3 2026 | Nov 16, 2026 |
| Rialto Wealth Management, Llc | Sell | -254 | -33.4% | 507 | $381.00 | Q3 2026 | Nov 16, 2026 |
| Royal Bank Of Canada | Sell | -2 | -2.5% | 78 | $0.00 | Q3 2026 | Nov 16, 2026 |
| Morgan Stanley | Sell | -289,200 | -92.1% | 24,722 | $18.56K | Q3 2026 | Nov 13, 2026 |
| Tocqueville Asset Management L.P. | Buy | +173,500 | — | 173,500 | $130.25K | Q3 2026 | Nov 13, 2026 |
| Quantinno Capital Management Lp | Sell | -90,418 | -14.1% | 551,759 | $414.20K | Q3 2026 | Nov 13, 2026 |
| Vanguard Capital Management Llc | Sell | -30,967 | -1.8% | 1,668,348 | $1.25M | Q3 2026 | Nov 13, 2026 |
| Northwestern Mutual Wealth Management Co | Buy | +10,972 | — | 10,972 | $8.24K | Q3 2026 | Nov 13, 2026 |
| Blackrock, Inc. | Sell | -8,743 | -1.4% | 598,896 | $449.59K | Q3 2026 | Nov 13, 2026 |
| Rockefeller Capital Management L.P. | Buy | +2,000 | +7.2% | 29,664 | $22.27K | Q3 2026 | Nov 13, 2026 |
| Militia Capital Management Llc | Buy | +1,328,778 | +400.5% | 1,660,578 | $1.25M | Q3 2026 | Nov 12, 2026 |
| Renaissance Technologies LLC | Buy | +369,146 | +146.4% | 621,346 | $466.44K | Q3 2026 | Nov 12, 2026 |
| Focus Partners Wealth | Sell | -90,418 | -14.1% | 551,759 | $414.20K | Q3 2026 | Nov 12, 2026 |
| Stifel Financial Corp | Buy | +60,000 | — | 60,000 | $45.04K | Q3 2026 | Nov 12, 2026 |
| Jpmorgan Chase & Co | Buy | +49,946 | +262873.7% | 49,965 | $37.12K | Q3 2026 | Nov 12, 2026 |
| Osaic Holdings, Inc. | Buy | +15,200 | +50.7% | 45,200 | $33.77K | Q3 2026 | Nov 12, 2026 |
| Ubs Group Ag | Buy | +224,370 | +2017.5% | 235,491 | $176.85K | Q3 2026 | Nov 10, 2026 |
| Group One Trading Llc | Buy | +105,580 | +2959.9% | 109,147 | $81.94K | Q3 2026 | Nov 10, 2026 |
| Acadian Asset Management Llc | Buy | +238,835 | — | 238,835 | $179.00 | Q3 2026 | Nov 09, 2026 |
| Ground Swell Capital, Llc | Buy | +12,054 | — | 12,054 | $9.05K | Q3 2026 | Nov 09, 2026 |
| Clearstead Advisors, Llc | Buy | +50,000 | — | 50,000 | $37.53K | Q3 2026 | Nov 06, 2026 |
| Geode Capital Management, Llc | Buy | +29,253 | +5.0% | 616,392 | $462.80K | Q3 2026 | Nov 06, 2026 |
| Barclays Plc | Sell | -580 | -99.7% | 2 | $2.00 | Q3 2026 | Nov 06, 2026 |
| Deutsche Bank Ag\ | Buy | +500 | — | 500 | $375.00 | Q3 2026 | Nov 06, 2026 |
| Simplex Trading, Llc | Buy | +137,520 | — | 137,520 | $103.28K | Q3 2026 | Nov 04, 2026 |
Frequently asked questions about PDSB activity
Which institutional owners are buying PDSB?
Institutional owners buying PDSB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PDSB activity?
"Buy" means an investor increased their reported position in PDSB compared to the prior reporting period. This reflects growing exposure to PDS BIOTECHNOLOGY CORP (PDSB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PDSB increasing?
Institutional interest in PDSB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related PDSB Institutional Insights
- PDSB Overview
- PDSB 13F Institutional Holders
- PDSB Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- PDSB Insider Trading & SEC Form 4 Activity
- PDSB Articles
- Top Institutional Investor Stock Rankings